Achievement of National Quality Standards in HER2-positive Breast Cancer: A Pilot Study on the Impact of Certified Education Plus a Novel Care Planning Tool
FOR REFERENCE ONLY
Release Date: July 27, 2015
Expiration Date: July 27, 2016
ESTIMATED TIME TO COMPLETE ACTIVITY:
1.75 hours
Jointly provided by Postgraduate Institute for Medicine and Carevive Systems, Inc. (formerly On Q Health)
TARGET AUDIENCE
The target audiences for these activities are medical oncologists, physician assistants, nurse practitioners, oncology nurses, nurse navigators, and palliative/symptom management teams.The target audiences for these activities are surgeons, surgical oncologists, medical oncologists, physician assistants, nurse practitioners, and oncology nurses.
LEARNING OBJECTIVES
After completing this activity, the participant should be better able to:
- Develop evidence-based treatment approaches for patients diagnosed with – breast cancer in the neoadjuvant, adjuvant and metastatic settings
- Recognize quality measures associated with the management of HER2-positive breast cancer
- Demonstrate collaboration with the multi-disciplinary cancer team to meet quality standards relevant to the management of HER2-positive breast cancer
- Formulate personalized care plans for patients with HER2-positive breast cancer to provide education and recommendations/referrals to manage cancer and cancer-related symptoms
- Recognize the evolving evidence on the management of chemotherapy-induced nausea and vomiting, diarrhea, chemotherapy-induced peripheral neuropathy, fatigue, lymphedema, bone health, weight gain, psychosocial distress (anxiety, fear of recurrence), menopausal symptoms, cardiotoxicity, mouth sores, and diarrhea
- Provide appropriate care and counsel for patients and their families
CO-CHAIRS
Douglas W. Blayney, MD
The Stanford University Medical Center
Paul Jacobsen, PhD
Moffitt Cancer Center
FACULTY
Linden Spital, NP
Lancaster General Health
Jeannine M. Brant PhD, APRN, AOCN
Billings Clinic Inpatient Cancer Care
Laura Zitella, MS, RN, ACNP-BC, AOCN
Stanford University Medical Center
Jacquelyn M. Powers, MS, CGC
Abramson Cancer Center, University of Pennsylvania
Gloria ‘Lita’ Smith
University of Michigan
Rita Wickham, PhD, RN, CHPN, AOCN
Rush University Medical Center College of Nursing
PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and On Q Health, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CONTINUING MEDICAL EDUCATION
Credit Designation
This educational activity for 1.6 contact hours is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by theAmerican Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related material that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
| Douglas W. Blayney, MD | No real or apparent conflict of interest to report. |
| Paul Jacobsen, PhD | No real or apparent conflict of interest to report. |
| Linden Spital, NP | No real or apparent conflict of interest to report. |
| Jeannine M. Brant PhD, APRN, AOCN | Consulting Fees, Insys; Speakers’ Bureaus, Insys, Genentech. |
| Laura Zitella, MS, RN, ACNP-BC, AOCN | Consulting Fees, Teva, Prometheus, VATA Medical Supply. |
| Jacquelyn M. Powers, MS, CGC, | Consulting Fees/Advisory Board, Pathway Genomics. |
| Gloria ‘Lita’ Smith | Speakers’ Bureau, Genentech BioOncology |
| Rita Wickham, PhD, RN, CHPN, AOCN | No real or apparent conflict of interest to report. |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Carevive Systems, Inc. planners and managers reported the following: Timothy J. DiChiara, PhD, Consulting Fees, Gilead Sciences; Karen Hammelef, DNP, RN, Speakers’ Bureau, Novartis Pharmaceuticals Corporation.
METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME credit for this activity. During the period July 27, 2015 through July 27, 2016 participants must read the learning objectives and faculty disclosures and study the educational activity. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 10752.. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
MEDIA
Monograph
HARDWARE AND SOFTWARE REQUIREMENTS
CME University requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
